
### [NCIT:C36310](http://purl.obolibrary.org/obo/NCIT_C36310)
**Label:** Secondary Carcinoma

**Subclasses:** [NCIT:C3345](http://purl.obolibrary.org/obo/NCIT_C3345) (Pseudomyxoma Peritonei), [NCIT:C133501](http://purl.obolibrary.org/obo/NCIT_C133501) (Breast Carcinoma Metastatic in the Central Nervous System), [NCIT:C8637](http://purl.obolibrary.org/obo/NCIT_C8637) (Metastatic Small Intestinal Carcinoma), [NCIT:C89815](http://purl.obolibrary.org/obo/NCIT_C89815) (Colon Carcinoma Metastatic in the Lung), [NCIT:C6334](http://purl.obolibrary.org/obo/NCIT_C6334) (Metastatic Carcinoma in the Uterine Cervix), [NCIT:C133503](http://purl.obolibrary.org/obo/NCIT_C133503) (Lung Carcinoma Metastatic in the Central Nervous System), [NCIT:C27382](http://purl.obolibrary.org/obo/NCIT_C27382) (Peritoneal Carcinomatosis), [NCIT:C27381](http://purl.obolibrary.org/obo/NCIT_C27381) (Metastatic Carcinoma in the Adrenal Cortex), [NCIT:C4124](http://purl.obolibrary.org/obo/NCIT_C4124) (Metastatic Adenocarcinoma), [NCIT:C5176](http://purl.obolibrary.org/obo/NCIT_C5176) (Metastatic Signet Ring Cell Breast Carcinoma), [NCIT:C5178](http://purl.obolibrary.org/obo/NCIT_C5178) (Metastatic Squamous Cell Breast Carcinoma), [NCIT:C3870](http://purl.obolibrary.org/obo/NCIT_C3870) (Lymphangitic Carcinomatosis), [NCIT:C27408](http://purl.obolibrary.org/obo/NCIT_C27408) (Metastatic Carcinoma in the Lung), [NCIT:C36082](http://purl.obolibrary.org/obo/NCIT_C36082) (Metastatic Carcinoma in the Bone), [NCIT:C3153](http://purl.obolibrary.org/obo/NCIT_C3153) (Krukenberg Tumor), [NCIT:C96767](http://purl.obolibrary.org/obo/NCIT_C96767) (Metastatic Carcinoma in the Liver), [NCIT:C36309](http://purl.obolibrary.org/obo/NCIT_C36309) (Colon Carcinoma Metastatic in the Liver), [NCIT:C8933](http://purl.obolibrary.org/obo/NCIT_C8933) (Metastatic Pancreatic Adenocarcinoma), [NCIT:C76326](http://purl.obolibrary.org/obo/NCIT_C76326) (Metastatic Ductal Breast Carcinoma), [NCIT:C8934](http://purl.obolibrary.org/obo/NCIT_C8934) (Metastatic Small Intestinal Adenocarcinoma), [NCIT:C66717](http://purl.obolibrary.org/obo/NCIT_C66717) (Metastatic Signet Ring Cell Carcinoma), [NCIT:C3482](http://purl.obolibrary.org/obo/NCIT_C3482) (Metastatic Carcinoma), [NCIT:C8064](http://purl.obolibrary.org/obo/NCIT_C8064) (Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter), [NCIT:C126109](http://purl.obolibrary.org/obo/NCIT_C126109) (Metastatic Urothelial Carcinoma), [NCIT:C36300](http://purl.obolibrary.org/obo/NCIT_C36300) (Breast Carcinoma Metastatic in the Lung), [NCIT:C36304](http://purl.obolibrary.org/obo/NCIT_C36304) (Lung Carcinoma Metastatic in the Brain), [NCIT:C36303](http://purl.obolibrary.org/obo/NCIT_C36303) (Breast Carcinoma Metastatic in the Bone), [NCIT:C76328](http://purl.obolibrary.org/obo/NCIT_C76328) (Metastatic Lobular Breast Carcinoma), [NCIT:C126465](http://purl.obolibrary.org/obo/NCIT_C126465) (Metastatic Head and Neck Carcinoma), [NCIT:C36302](http://purl.obolibrary.org/obo/NCIT_C36302) (Breast Carcinoma Metastatic in the Liver), [NCIT:C36301](http://purl.obolibrary.org/obo/NCIT_C36301) (Breast Carcinoma Metastatic in the Brain), [NCIT:C36308](http://purl.obolibrary.org/obo/NCIT_C36308) (Prostate Carcinoma Metastatic in the Bone), [NCIT:C5628](http://purl.obolibrary.org/obo/NCIT_C5628) (Carcinoma Metastatic in the Skin), [NCIT:C36307](http://purl.obolibrary.org/obo/NCIT_C36307) (Prostate Carcinoma Metastatic in the Lung), [NCIT:C36306](http://purl.obolibrary.org/obo/NCIT_C36306) (Lung Carcinoma Metastatic in the Liver), [NCIT:C36305](http://purl.obolibrary.org/obo/NCIT_C36305) (Lung Carcinoma Metastatic in the Bone), [NCIT:C28311](http://purl.obolibrary.org/obo/NCIT_C28311) (Breast Carcinoma Metastatic in the Skin), [NCIT:C27384](http://purl.obolibrary.org/obo/NCIT_C27384) (Pleural Carcinomatosis), [NCIT:C8944](http://purl.obolibrary.org/obo/NCIT_C8944) (Vaginal Metastatic Adenocarcinoma), [NCIT:C27185](http://purl.obolibrary.org/obo/NCIT_C27185) (Disseminated Adenocarcinoma), [NCIT:C27383](http://purl.obolibrary.org/obo/NCIT_C27383) (Meningeal Carcinomatosis), [NCIT:C8945](http://purl.obolibrary.org/obo/NCIT_C8945) (Metastatic Prostatic Adenocarcinoma), [NCIT:C4104](http://purl.obolibrary.org/obo/NCIT_C4104) (Metastatic Squamous Cell Carcinoma), [NCIT:C8942](http://purl.obolibrary.org/obo/NCIT_C8942) (Metastatic Endometrial Adenocarcinoma), [NCIT:C27385](http://purl.obolibrary.org/obo/NCIT_C27385) (Pericardial Carcinomatosis), [NCIT:C8943](http://purl.obolibrary.org/obo/NCIT_C8943) (Metastatic Endometrioid Adenocarcinoma), [NCIT:C133193](http://purl.obolibrary.org/obo/NCIT_C133193) (Metastatic Thyroid Gland Carcinoma), [NCIT:C27469](http://purl.obolibrary.org/obo/NCIT_C27469) (Disseminated Carcinoma), [NCIT:C3693](http://purl.obolibrary.org/obo/NCIT_C3693) (Carcinomatosis), [NCIT:C9276](http://purl.obolibrary.org/obo/NCIT_C9276) (Metastatic Carcinoma in the Adrenal Medulla), [NCIT:C129828](http://purl.obolibrary.org/obo/NCIT_C129828) (Metastatic Transitional Cell Carcinoma), [NCIT:C4829](http://purl.obolibrary.org/obo/NCIT_C4829) (Disseminated Squamous Cell Carcinoma), [NCIT:C133839](http://purl.obolibrary.org/obo/NCIT_C133839) (Metastatic Gastrointestinal Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 52.40%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36662](http://purl.obolibrary.org/obo/NCIT_C36662) (Transforming Growth Factor-Beta Overexpression))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36660](http://purl.obolibrary.org/obo/NCIT_C36660) (Monoclonal Hepatocyte Population Present))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36659](http://purl.obolibrary.org/obo/NCIT_C36659) (CTNNB1 Gene Mutation))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36658](http://purl.obolibrary.org/obo/NCIT_C36658) (Gain of Chromosome Xq))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36657](http://purl.obolibrary.org/obo/NCIT_C36657) (Polysomy 17))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36656](http://purl.obolibrary.org/obo/NCIT_C36656) (Polysomy 10))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36655](http://purl.obolibrary.org/obo/NCIT_C36655) (Polysomy 3))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36654](http://purl.obolibrary.org/obo/NCIT_C36654) (CDH1 Gene Inactivation))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36652](http://purl.obolibrary.org/obo/NCIT_C36652) (CCND1 Gene Amplification))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36651](http://purl.obolibrary.org/obo/NCIT_C36651) (FGFR2 Gene Amplification))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36650](http://purl.obolibrary.org/obo/NCIT_C36650) (FGFR1 Gene Amplification))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36649](http://purl.obolibrary.org/obo/NCIT_C36649) (EGFR Gene Amplification))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C36648](http://purl.obolibrary.org/obo/NCIT_C36648) (der(1;16)(q10;p10)))) 40.91%


